These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1455 related articles for article (PubMed ID: 19174792)

  • 1. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
    Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis.
    Sood A; Midha V; Makharia GK; Ahuja V; Singal D; Goswami P; Tandon RK
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1202-9, 1209.e1. PubMed ID: 19631292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose probiotics for the treatment of active pouchitis.
    Gionchetti P; Rizzello F; Morselli C; Poggioli G; Tambasco R; Calabrese C; Brigidi P; Vitali B; Straforini G; Campieri M
    Dis Colon Rectum; 2007 Dec; 50(12):2075-82; discussion 2082-4. PubMed ID: 17934776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice.
    Shen B; Brzezinski A; Fazio VW; Remzi FH; Achkar JP; Bennett AE; Sherman K; Lashner BA
    Aliment Pharmacol Ther; 2005 Oct; 22(8):721-8. PubMed ID: 16197493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
    Hanauer S; Good LI; Goodman MW; Pizinger RJ; Strum WB; Lyss C; Haber G; Williams CN; Robinson M
    Am J Gastroenterol; 2000 Jul; 95(7):1749-54. PubMed ID: 10925979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
    Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
    Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
    Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
    Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis.
    Zocco MA; dal Verme LZ; Cremonini F; Piscaglia AC; Nista EC; Candelli M; Novi M; Rigante D; Cazzato IA; Ojetti V; Armuzzi A; Gasbarrini G; Gasbarrini A
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1567-74. PubMed ID: 16696804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.
    Henker J; Müller S; Laass MW; Schreiner A; Schulze J
    Z Gastroenterol; 2008 Sep; 46(9):874-5. PubMed ID: 18810672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.
    Tursi A; Brandimarte G; Giorgetti GM; Forti G; Modeo ME; Gigliobianco A
    Med Sci Monit; 2004 Nov; 10(11):PI126-31. PubMed ID: 15507864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
    Mantzaris GJ; Archavlis E; Christoforidis P; Kourtessas D; Amberiadis P; Florakis N; Petraki K; Spiliadi C; Triantafyllou G
    Am J Gastroenterol; 1997 Mar; 92(3):454-6. PubMed ID: 9068468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
    Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study.
    Huynh HQ; deBruyn J; Guan L; Diaz H; Li M; Girgis S; Turner J; Fedorak R; Madsen K
    Inflamm Bowel Dis; 2009 May; 15(5):760-8. PubMed ID: 19067432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.